Sildenafil Tablet, Film Coated
Product Images NDC 72865-105

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72865-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

90scount.jpg (90scount)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This text provides recommendations for drug dose adjustments based on changes in drug fold change and 90% confidence interval (CI) for various medications including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. The text also includes the change relative to Sildenafil alone and a solid line indicating the vertical change at x=1. There is also a note on AUC accumulation ratio from Day 1 to Day 7 related to Sildenafil.*

FDA Label Image

Figure3 (Figure3)

This text appears to be a list of drugs that interact with Acenocoumarol, and the effect of these interactions on various pharmacokinetics parameters such as AUC and Cmax. The text also mentions a recommendation on whether or not to adjust the dose of the interacting drug, and whether co-administration is recommended or not. The text further explains the effect of adding sildenafi to bosentan therapy or ritonavir on sidenail PK.*

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.